|
Aarti
Industries consolidated net sales increased 45.17% to Rs 1755.64 crore. Sales of Speciality Chemicals segment has
gone up 45.09% to Rs 1,629.35 crore (accounting for 80.75% of total sales). Sales of Pharmaceuticals segment has gone up
73.56% to Rs 388.47 crore (accounting for 19.25% of total sales). Inter-segment sales rose Rs 137.45 crore to
Rs 262.18 crore.
Operating
profit margin has declined from 21.52% to 19.32%, leading to 30.28% rise in
operating profit to Rs 339.11 crore. Raw
material cost as a % of total sales (net of stock adjustments) increased from
44.07% to 49.28%. Purchase of finished
goods cost rose from 4.08% to 5.19%.
Employee cost decreased from 7.78% to 6.56%. Other expenses fell from 23.33% to
20.46%.
Other
income rose 1,600% to Rs 0.17 crore.
PBIDT rose 30.34% to Rs 339.28 crore. Profit before interest, tax and
other unallocable items (PBIT) has jumped 21.47% to Rs 312.36 crore. PBIT of Speciality Chemicals segment rose
17.14% to Rs 245.60 crore (accounting for 78.63% of total PBIT). PBIT of Pharmaceuticals segment rose 40.61%
to Rs 66.76 crore (accounting for 21.37% of total PBIT).
PBIT
margin of Speciality Chemicals segment fell from 18.67% to 15.07%. PBIT margin of Pharmaceuticals segment fell
from 21.21% to 17.19%. Overall PBIT
margin fell from 19.09% to 15.48%.
Provision
for interest rose 41.63% to Rs 30.62 crore. PBDT rose 29.31% to Rs 308.66 crore. Provision for depreciation rose 17.66% to Rs
77.23 crore.
Profit
before tax grew 33.74% to Rs 231.43 crore.
Provision for tax was expense of Rs 37.68 crore, compared to Rs 33.71
crore. Effective tax rate was 16.28%
compared to 19.48%.
Minority
interest decreased 99.38% to Rs 0.02 crore.
Net profit attributable to owners of the company increased 42.34% to Rs
193.73 crore.
Equity
capital increased from Rs 87.12 crore as of 31 March 2021 to Rs 181.25 crore as
of 31 March 2022. Per share face Value
remained same at Rs 5.00.
Promoters’
stake was 44.19% as of 31 March 2022 compared to 46.82% as of 31 March 2021
.
Full year results
analysis
Net
sales of Aarti Industries has increased
55.34% to Rs 6999.96 crore. Sales of
Speciality Chemicals segment has gone up 62.60% to Rs 6,619.38 crore
(accounting for 83.59% of total sales).
Sales of Pharmaceuticals segment has gone up 36.50% to Rs 1,299.93 crore
(accounting for 16.41% of total sales).
Inter-segment sales rose Rs 517.18 crore to Rs 919.35 crore.
Operating
profit margin has jumped from 21.78% to 27.55%, leading to 96.51% rise in
operating profit to Rs 1,928.81 crore.
Raw material cost as a % of total sales (net of stock adjustments)
increased from 42.50% to 45.01%.
Purchase of finished goods cost fell from 5.36% to 3.95%. Employee cost decreased from 8.15% to 6.09%. Other expenses fell from 22.47% to
18.39%.
Other
income rose 14.29% to Rs 0.8 crore.
PBIDT rose 96.45% to Rs 1929.61 crore.
Profit before interest, tax and other unallocable items (PBIT) has
jumped 91.60% to Rs 1,834.26 crore. PBIT
of Speciality Chemicals segment rose 116.24% to Rs 1,613.93 crore (accounting
for 87.99% of total PBIT). PBIT of
Pharmaceuticals segment rose 4.44% to Rs 220.33 crore (accounting for 12.01% of
total PBIT).
PBIT
margin of Speciality Chemicals segment rose from 18.33% to 24.38%. PBIT margin of Pharmaceuticals segment fell
from 22.15% to 16.95%. Overall PBIT
margin rose from 19.06% to 23.16%.
Provision
for interest rose 32.33% to Rs 114.29 crore.
Loan funds declined from Rs 2,492.12 crore as of 31 March 2021 to Rs
2,217.62 crore as of 31 March 2022.
Inventories rose to Rs 1,411.33 crore as of 31 March 2022 from Rs 935.68
crore as of 31 March 2021. Sundry
debtors were higher at Rs 1,390.50 crore as of 31 March 2022 compared to Rs
793.73 crore as of 31 March 2021. Cash
and bank balance declined from Rs 412.32 crore as of 31 March 2021 to Rs 256.84
crore as of 31 March 2022. Investments
rose to Rs 73.13 crore as of 31 March 2022 from Rs 63.52 crore as of 31 March
2021 .
PBDT
rose 102.63% to Rs 1815.32 crore.
Provision for depreciation rose 24.73% to Rs 288.52 crore. Fixed assets increased to Rs 5,908.12 crore
as of 31 March 2022 from Rs 4,890.39 crore as of 31 March 2021. Intangible assets increased from Rs 0.10
crore to Rs 0.19 crore.
Profit
before tax grew 129.75% to Rs 1,526.80 crore.
Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs 219.38
crore, compared to Rs 129.33 crore.
Effective tax rate was 14.37% compared to 19.46%.
Minority
interest decreased 98.04% to Rs 0.23 crore.
Net profit attributable to owners of the company increased 149.72% to Rs
1,307.19 crore.
Equity
capital increased from Rs 87.12 crore as of 31 March 2021 to Rs 181.25 crore as
of 31 March 2022. Per share face Value
remained same at Rs 5.00.
Promoters’
stake was 44.19% as of 31 March 2022 ,compared to 46.82% as of 31 March 2021
.
Cash
flow from operating activities decreased to Rs 470.76 crore for year ended
March 2022 from Rs 872.71 crore for year ended March 2021. Cash flow used in acquiring fixed assets
during the year ended March 2022 stood at Rs 1,306.57 crore, compared to Rs
1,314.82 crore during the year ended March 2021.
The
scrip trades at Rs 765
|
Aarti Industries : Consolidated Results
|
|
Particulars
|
2203 (03)
|
2103 (03)
|
Var.(%)
|
2203 (12)
|
2103 (12)
|
Var.(%)
|
|
Net Sales
|
1,755.64
|
1,209.35
|
45
|
6,999.96
|
4,506.10
|
55
|
|
OPM (%)
|
19.3
|
21.5
|
|
27.6
|
21.8
|
|
|
OP
|
339.11
|
260.3
|
30
|
1,928.81
|
981.53
|
97
|
|
Other Inc.
|
0.17
|
0.01
|
999
|
0.8
|
0.7
|
14
|
|
PBIDT
|
339.28
|
260.31
|
30
|
1,929.61
|
982.23
|
96
|
|
Interest
|
30.62
|
21.62
|
42
|
114.29
|
86.37
|
32
|
|
PBDT
|
308.66
|
238.69
|
29
|
1,815.32
|
895.86
|
103
|
|
Depreciation
|
77.23
|
65.64
|
18
|
288.52
|
231.31
|
25
|
|
PBT
|
231.43
|
173.05
|
34
|
1526.8
|
664.55
|
130
|
|
Share of Profit/(Loss) from Associates
|
0
|
0
|
-
|
0
|
0
|
-
|
|
PBT before EO
|
231.43
|
173.05
|
34
|
1526.8
|
664.55
|
130
|
|
EO Income
|
0
|
0
|
-
|
0
|
0
|
-
|
|
PBT after EO
|
231.43
|
173.05
|
34
|
1526.8
|
664.55
|
130
|
|
Taxation
|
37.68
|
33.71
|
12
|
219.38
|
129.33
|
70
|
|
PAT
|
193.75
|
139.34
|
39
|
1307.42
|
535.22
|
144
|
|
Minority Interest (MI)
|
0.02
|
3.24
|
-99
|
0.23
|
11.75
|
-98
|
|
Net profit
|
193.73
|
136.1
|
42
|
1307.19
|
523.47
|
150
|
|
EPS (Rs)*
|
#
|
#
|
|
36.1
|
14.4
|
|
|
Notes
|
|
* EPS is on current equity of Rs 181.25 crore, Face value of Rs
5, Excluding extraordinary items.
|
|
# EPS is not annualised
|
|
bps : Basis points
|
|
EO : Extraordinary items
|
|
Figures in Rs crore
|
|
Source: Capitaline Corporate Database
|
|
Aarti Industries : Consolidated Segment Results
|
|
|
% of (Total)
|
2203 (03)
|
2103 (03)
|
Var.(%)
|
% of (Total)
|
2203 (12)
|
2103 (12)
|
Var.(%)
|
|
Sales
|
|
Speciality Chemicals
|
81
|
1,629.35
|
1,122.97
|
45
|
84
|
6,619.38
|
4,070.98
|
63
|
|
Pharmaceuticals
|
19
|
388.47
|
223.83
|
74
|
16
|
1,299.93
|
952.3
|
37
|
|
Total Reported Sales
|
100
|
2,017.82
|
1,346.80
|
50
|
100
|
7,919.31
|
5,023.28
|
58
|
|
Less: Inter segment revenues
|
|
262.18
|
137.45
|
91
|
|
919.35
|
517.18
|
78
|
|
Net Sales
|
|
1,755.64
|
1,209.35
|
45
|
|
6,999.96
|
4,506.10
|
55
|
|
PBIT
|
|
Speciality Chemicals
|
79
|
245.6
|
209.67
|
17
|
88
|
1,613.93
|
746.37
|
116
|
|
Pharmaceuticals
|
21
|
66.76
|
47.48
|
41
|
12
|
220.33
|
210.96
|
4
|
|
Total PBIT
|
100
|
312.36
|
257.15
|
21
|
100
|
1,834.26
|
957.33
|
92
|
|
Less : Interest
|
|
30.62
|
21.62
|
42
|
|
114.29
|
86.37
|
32
|
|
Add: Other un-allcoable
|
|
-50.31
|
-62.48
|
19
|
|
-193.17
|
-206.41
|
6
|
|
PBT
|
|
231.43
|
173.05
|
34
|
|
1,526.80
|
664.55
|
130
|
|